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a daycare centre increased the odds of the development of 
AD between 6 and 12 months (aOR 4.19, 95% CI 1.01–17.45, 
p =  0.049 and aOR 11.42, 95% CI 1.49–87.50, p = 0.02, respec-
tively). Risk factors associated with increased odds of late-
onset AD from 12 months were the consumption of probiot-
ics between the age of 9 and 12 months and antibiotic treat-
ment in the first 6 months of life (aOR 4.32, 95% CI 1.07–17.45, 
p = 0.04 and aOR 3.11, 95% CI 1.10–8.76, p = 0.03, respec-
tively). Early-onset AD was associated with an increased risk 
of developing allergic sensitization (aOR 46.51, 95% CI 3.44–
628.81, p < 0.01).  Conclusion: We found that early-onset AD 
was mainly associated with familial factors, while late-onset 
AD was associated with the consumption of antibiotics or 
probiotics. The findings support the concept that different 
phenotypes of AD exist in young children. 
 © 2015 S. Karger AG, Basel 
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 Abstract 
 Background: Atopic dermatitis (AD) has been highlighted as 
a likely first step in the ‘atopic march’, emphasizing the need 
to define predisposing factors.  Methods: We evaluated AD 
risk factors and phenotypes in an Asian mother-offspring co-
hort . We defined three phenotypes of doctor-diagnosed AD 
based on the time of onset of the disease: early AD occurring 
within the first 6 months of life, AD occurring between 6 and 
12 months and late-onset AD starting after the age of 12 
months.  Results: Maternal allergic history was associated 
with an increased risk of developing early-onset AD (adjust-
ed odds ratio (aOR) 20.46, 95% confidence interval (CI) 2.73–
153.15, p < 0.01). Maternal allergic history and attendance at 
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 There is a wide geographical variation in the prevalence 
of allergic diseases such as atopic dermatitis (AD) in differ-
ent regions  [1] , suggesting that there may be location-spe-
cific factors such as environment, lifestyle and microbial 
exposure affecting the onset of disease  [2] . In Singapore, 
two International Study of Asthma and Allergies in Child-
hood surveys were conducted 7 years apart in 2 age groups 
(6–7 and 12–15 years). The prevalence of AD, but not of 
allergic disorders, increased in both age groups over the 
7-year period  [3] . AD is known to start early in life, with 
incidences of up to 45 and 60% having been reported in the 
first 6 and 12 months of life, respectively  [4, 5] . In a study 
of Singaporean school children, the reported prevalence of 
AD was 20.8%  [6] while in another study, a chronic itchy 
rash was found to affect 22.1% of Singaporean children, 
although AD was only diagnosed in 34.4% of these cases 
 [6, 7] . AD has also been highlighted in many studies to be 
a likely first step of the ‘atopic march’. Hence, it is vital to 
pinpoint the factors that may lead to or predispose a child 
to developing AD  [8] . In this study, we evaluated risk fac-
tors and phenotypes of AD by studying its features in an 
Asian mother-offspring cohort, GUSTO (Growing Up in 
Singapore Towards healthy Outcomes). We postulated 
that different risk factors might be responsible for different 
AD phenotypes, according to the time of disease onset. We 
distinguished three phenotypes of AD based on the time of 
onset of the disease: early AD occurring within the first 
6 months of life, AD occurring between 6 and 12 months 
and late-onset AD starting after the age of 12 months.
 Methods 
 Study Population and Questionnaires 
 The methodology of the GUSTO study has been described  [9, 
10] . Briefly, we recruited healthy pregnant mothers who agreed to 
donate birth tissue (i.e. placenta, cord blood and cord) and con-
sented to follow-up of their offspring. Mothers on chemotherapy, 
psychotropic drugs or with type I diabetes were excluded. Inter-
views were carried out and the information gathered included de-
mographics, a family history of allergy, social data and lifestyle. 
During infancy, examinations of the babies were carried out at 
their homes at the age of 3 weeks and at 3, 6, 9, 12 and 15 months, 
following which, skin-prick testing (SPT) for common allergens 
was performed at the study clinic site, at the age of 18 months. In 
this study, the questionnaires included a case definition of AD, 
adapted and modified from the International Study of Asthma and 
Allergy in Children, to ensure standardization and consistency 
during interviews and home visits  [11] . Doctor-diagnosed AD cas-
es were estimated on the basis of positive answers to the question: 
‘Has your child ever been diagnosed with eczema?’ AD was classi-
fied as YES when a subject had at least one YES answer at any 
visit and classified as NO when answers at all the visits were NO. 
A missing response was given if some of the answers from the vis-
its were missing.
 Socioeconomic status was assessed by asking respondents to 
state the total family income and the type of residence (public 
housing, condominium or landed houses). Environmental factors 
were assessed by asking respondents if the child was sent to a child-
care/daycare centre, if pets such as cats and dogs were kept and if 
there was exposure to cigarette smoke. This study was approved by 
both the National Healthcare Group Domain Specific Review 
Board and the Singhealth Centralised Institutional Review Board.
 SPT at the Age of 18 Months 
 At the 18-month clinic visit, children underwent SPT for aero-
allergens (house-dust mites  Dermatophagoides pteronyssinus ,  D. 
farinae  and Blomia tropicalis ) and food allergens (egg, peanut and 
cow’s milk). A test was taken to be positive if the wheal size was at 
least 3 mm, and if a histamine reaction was at least 3 mm and a 
buffer reaction 0 mm.
 Statistical Analysis 
 Statistical analysis was carried out using SPSS version 20.0 
(IBM SPSS Statistics, Armonk, N.Y., USA). Logistic regression was 
used to determine the univariate associations between the poten-
tial risk factors and the outcome. Risk factors with a p value <0.200 
in univariate analysis were then analyzed via multivariate logistic 
regression and the stepwise backward Wald method to determine 
if they were independent risk factors.
 Results 
 Demographic Characteristics of the Birth Cohort 
 Of the 1,247 subjects recruited into the GUSTO co-
hort, 792 (63.5%) subjects had responses (i.e. YES or NO) 
to questions related to doctor-diagnosed AD. Out of these 
792 subjects, 51.9% were male and the majority were 
 Chinese (60.2%). Malays and Indians made up 24.2% and 
15.5% of the study population, respectively.
 Prevalence Based on Questionnaires 
 Doctor-diagnosed AD was reported by 23.6% 
(187/792). Of these, 53.5% (100/187) were diagnosed be-
fore the age of 6  months, 23.0% (43/187) had the diagno-
sis between 6 and 12 months and 25.1% (47/187) were 
diagnosed after 12 months of age.
 Risk Factors of Doctor-Diagnosed AD 
 A univariate analysis of risk factors for doctor-diag-
nosed AD is shown in  table 1 . At the univariate level, risk 
factors associated with an increased risk of developing doc-
tor-diagnosed AD were maternal consumption of alcohol, 
a maternal history of allergy, the maternal education level 
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95% confidence interval (CI) 1.03–8.04, p = 0.04; OR 2.27, 
95% CI 1.42–3.62, p  ≤ 0.01; OR 1.67, 95% CI 1.09–2.56, p = 
0.02; OR 1.79, 95% CI 1.27–2.54, p  ≤ 0.01, respectively). 
Factors associated with decreased odds of developing doc-
tor-diagnosed AD in univariate analysis were female gen-
der and Indian ethnicity (OR 0.68, 95% CI 0.49–0.94, p = 
0.02 and OR 0.48, 95% CI 0.28–0.83, p  ≤ 0.01, respectively).
 A multivariate analysis showed that having siblings and 
being of Indian ethnicity were associated with reduced odds 
of developing doctor-diagnosed AD (adjusted (a)OR 0.46, 
95% CI 0.22–0.95, p = 0.04 and aOR 0.14, 95% CI 0.03–0.65, 
p = 0.01, respectively;  table 2 ). A maternal allergic history 
was associated with increased odds of developing doctor-
diagnosed AD (aOR 3.15, 95% CI 1.51–6.57, p  ≤ 0.01).
 Table 1.  Findings in bivariate analyses of doctor-diagnosed AD cases with explanatory and outcome parameters
Outcome factor Explanatory parameter p value OR (95% CI)
Doctor-diagnosed AD cases
Has siblings 0.06 0.69 (0.47–1.02)
Maternal consumption of alcohol 0.04 2.87 (1.03–8.04)
Maternal smoking during pregnancy 0.17 0.36 (0.08–1.54)
Maternal allergic history <0.01 2.27 (1.42–3.62)
Paternal allergic history 0.18 1.42 (0.85–2.39)
Female gender 0.02 0.68 (0.49–0.94)
Maternal education level 0.02 1.67 (1.09–2.56)
Ethnicity (Chinese) 0.03 1.00
Ethnicity (Malay) 0.38 0.84 (0.57–1.24)
Ethnicity (Indian) <0.01 0.48 (0.28–0.83)
Birth weight 0.12 1.00 (1.000–1.001)
Birth length 0.15 1.06 (0.98–1.14)
Body fat 0.17 2.32 (0.70–7.72)
Monthly household income <0.01 1.79 (1.27–2.54)
Doctor-diagnosed AD cases from birth to 6 months
Maternal consumption of alcohol 0.03 3.51 (1.17–10.49)
Maternal allergic history 0.01 2.07 (1.16–3.72)
Paternal allergic history 0.17 1.57 (0.83–2.97)
Sibling allergic history 0.17 2.36 (0.70–7.94)
Maternal education level 0.03 1.87 (1.07–3.27)
Ethnicity (Chinese) 0.16 1.00
Ethnicity (Malay) 0.78 0.93 (0.57–1.53)
Ethnicity (Indian) 0.06 0.49 (0.24–1.02)
Monthly household income 0.07 1.51 (0.97–2.34)
Doctor-diagnosed AD cases from 6 months to 12 months
Maternal allergic history 0.03 2.50 (1.12–5.62)
Vaginal delivery 0.11 0.60 (0.32–1.13)
Antibiotic treatment in the first 6 months of life 0.02 2.40 (1.17–4.95)
Attended daycare <0.01 3.56 (1.38–9.21)
Having a cat 0.11 2.85 (0.80–10.13)
Having a dog 0.09 2.37 (0.87–6.47)
Living near an expressway 0.17 0.36 (0.08–1.53)
Female gender <0.01 0.35 (0.18–0.71)
Maternal education level 0.03 0.41 (0.18–0.92)
Doctor-diagnosed AD cases from 12 to 18 months
Has siblings 0.10 0.58 (0.30–1.12)
Prenatal exposure to smoke 0.14 0.59 (0.30–1.20)
Consumption of probiotics between 9 and 12 months 0.06 2.85 (0.95–8.61)
Antibiotic treatment in the first 6 months of life 0.02 2.30 (1.15–4.60)
Sum of skinfold thickness at birth 0.20 1.09 (0.96–1.24)
Maternal education level 0.02 3.04 (1.23–7.48)
Birth weight 0.05 1.001 (0.999–1.001)
Birth length 0.07 1.13 (0.99–1.30)
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 The univariate analysis showed the risk factors associ-
ated with increased odds of developing early doctor-diag-
nosed AD, i.e. before the age of 6 months, were maternal 
consumption of alcohol, a maternal allergic history and 
the maternal education level (OR 3.51, 95% CI 1.17–
10.49, p = 0.03; OR 2.07, 95% CI 1.16–3.72, p = 0.01; OR 
1.87, 95% CI 1.07–3.27, p = 0.03, respectively;  table 1 ). In 
the multivariate analysis, a maternal allergic history re-
mained a significant risk factor (aOR 20.46, 95% CI 2.73–
153.15, p  ≤ 0.01;  table 2 ).
 A maternal allergic history, antibiotic treatment in the 
first 6 months of life and attendance at a daycare centre were 
significantly associated with increased odds of developing 
AD between 6 and 12 months, while female gender and the 
maternal education level were protective effects at the uni-
variate analysis level. The multivariate analysis revealed that 
a maternal allergic history and daycare centre attendance 
increased the odds of development of AD between the ages 
of 6 and 12 months (aOR 4.19, 95% CI 1.01–17.45, p = 0.049 
and aOR 11.42, 95% CI 1.49–87.50, p = 0.02, respectively) 
while a higher level of maternal education reduced the odds 
(aOR 0.16, 95% CI 0.03–0.88, p = 0.04;  table 2 ).
 The univariate analysis showed that antibiotic treat-
ment in the first 6 months of life, the maternal education 
 Table 2.  Findings in the multivariate analyses of doctor-diagnosed AD cases with explanatory and outcome pa-
rameters
Outcome factor Explanatory parameter p value OR (95% CI)
Doctor-diagnosed AD cases
Has siblings 0.04 0.46 (0.22–0.95)
Maternal consumption of alcohol 0.28 3.27 (0.39–27.53)
Prenatal smoking 0.97 0.95 (0.10–9.42)
Maternal allergic history <0.01 3.15 (1.51–6.57)
Paternal allergic history 0.55 1.27 (0.58–2.79)
Female gender 0.24 2.01 (0.63–6.38)
Maternal education level 0.62 1.24 (0.53–2.89)
Ethnicity (Chinese) 0.04 1.00
Ethnicity (Malay) 0.85 0.92 (0.41–2.11)
Ethnicity (Indian) 0.01 0.14 (0.03–0.65) 
Birth weight 0.29 1.00 (0.998–1.01
Birth length 0.68 0.95 (0.75–1.20)
Body fat 0.44 0.02 (0.001–585.91)
Monthly household income 0.73 0.85 (0.34–2.11)
Doctor-diagnosed AD cases from birth to 6 months
Maternal allergic history <0.01 20.46 (2.73–153.15)
Paternal allergic history 0.12 5.30 (0.67–42.20)
Sibling allergic history 0.32 2.50 (0.41–15.19)
Maternal education level 0.71 0.64 (0.06–7.08)
Monthly household income 0.48 2.61 (0.18–37.96)
Doctor-diagnosed AD cases from 6 to 12 months
Maternal allergic history 0.049 4.19 (1.01–17.45)
Vaginal delivery 0.72 0.75 (0.15–3.61)
Antibiotic treatment in the first 6 months of life 0.13 3.19 (0.72–14.11)
Attended daycare 0.02 11.42 (1.49–87.50)
Having a dog 0.16 3.76 (0.60–23.59)
Female gender 0.23 0.35 (0.06–1.92)
Maternal education level 0.04 0.16 (0.03–0.88)
Doctor-diagnosed AD cases from 12 to 18 months
Has siblings 0.54 0.75 (0.30–1.87)
Prenatal exposure to smoke 0.95 0.96 (0.30–3.04)
Consumption of probiotics between 9 and 12 months 0.04 4.32 (1.07–17.45)
Antibiotic treatment in the first 6 months of life 0.03 3.11 (1.10–8.76)
Sum of skinfold thickness at birth 0.27 1.14 (0.90–1.44)
Maternal education level 0.08 3.61 (0.85–15.40)
Birth weight 0.59 1.00 (0.999–1.002)
Birth length 0.78 0.96 (0.70–1.30)
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level and the monthly household income were associated 
with increased odds of late-onset AD, i.e. between 12 and 
18 months of age (OR 2.30, 95% CI 1.15–4.60, p = 0.02; 
OR 3.04, 95% CI 1.23–7.48, p = 0.02; OR 2.93, 95% CI 
1.59–5.40, p  ≤ 0.01, respectively). Multivariate analysis 
showed that consumption of probiotics between the ages 
of 9 and 12 months and antibiotic treatment in the first 
6 months of life were associated with increased odds of 
developing AD between the ages of 12 and 18 months 
(aOR 4.32, 95% CI 1.07–17.45, p = 0.04 and aOR 3.11, 
95% CI 1.10–8.76, p = 0.03, respectively;  table 2 ). Out of 
the 12 subjects who developed AD between the ages of 12 
and 18 months and taken antibiotics in the first 6 months 
of life, the majority (n = 5) were due to respiratory tract 
infections.
 Risk Factors for Allergic Sensitization 
 Of the 792 subjects who responded to the question on 
doctor-diagnosed AD, 696 underwent SPT for house-dust 
mites and food allergens. Sixty (8.62%) had a positive SPT 
to house-dust mites while 18 (2.59%) had a positive SPT to 
food allergens only. Six hundred and two subjects (86.5%) 
did not have any positive SPTs while 16 (2.3%) had positive 
SPTs to both dust mite and food allergens. In the multi-
variate analyses, only an early onset of doctor-diagnosed 
AD by 6 months was associated with an increased risk of a 
positive SPT to house-dust mites and/or food allergens 
(aOR 46.51, 95% CI 3.44–628.81, p  ≤ 0.01;  table 3 ).
 Discussion 
 In this study, we defined three phenotypes of AD based 
on the time of onset of the disease: early AD occurring 
within the first 6 months of life, AD developing between 
the ages of 6 and 12 months and late-onset AD starting 
after the age of 12 months. In a previous study, there had 
been evidence of the presence of two variants of eczema 
that were attributed to different risk factors  [12] . There-
fore, because of the variations in the clinical presentation 
of AD (i.e. severity, skin type and age of onset), we postu-
lated that different risk factors might be involved, mainly 
in the types of AD occurring at both ends of the spectrum 
(i.e. onset during the first months of life vs. onset beyond 
the age of 12 months).
 The prevalence of doctor-diagnosed AD according to 
the questionnaire was 23.6%, which was similar to that 
reported previously  [7] . The involvement of parental his-
 Table 3.  Findings in bivariate and multivariate analyses of positive SPT at 18 months with explanatory and out-
come parameters
Outcome factor Explanatory parameter p value OR (95% CI)
Bivariate analyses
Positive SPT Onset of AD by 6 months of age <0.01 4.58 (2.71–7.76)
Maternal consumption of alcohol 0.14 2.38 (0.74–7.61)
Paternal allergic history 0.09 1.62 (0.92–2.85)
Sibling allergic history 0.15 2.03 (0.78–5.30)
Breastfed till 3 months 0.03 1.60 (1.04–2.45)
Breastfed till 6 months 0.09 1.43 (0.95–2.16)
Breastfed till 18 months 0.06 1.72 (0.98–3.01)
Antibiotic treatment in the first 6 months of life 0.14 0.59 (0.30–1.18)
Having a cat 0.12 2.29 (0.81–6.50)
Living near an expressway 0.11 1.68 (0.88–3.19)
Exposed to air-conditioning 0.14 0.65 (0.37–1.15)
Female gender 0.10 0.72 (0.48–1.07)
Ethnicity (Chinese) 0.04 1.00
Ethnicity (Malay) 0.36 1.23 (0.79–1.92)
Ethnicity (Indian) 0.04 0.50 (0.26–0.97)
Multivariate analyses
Positive SPT Onset of AD by 6 months of age <0.01 46.51 (3.44–628.81)
Sibling allergic history 0.41 2.28 (0.32–16.11)
Antibiotic treatment in the first 6 months of life 0.13 11.44 (0.50–260.29)
Living near an expressway 0.44 2.37 (0.27–21.24)
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tory of allergy in predisposing the infant to developing 
allergic diseases is well-established and widely reported 
by many groups  [13–15] . Similar to our observations of 
Indian ethnicity reducing the odds of developing AD 
compared to being Chinese, another study conducted on 
the local population yielded similar findings of a higher 
frequency of AD in Chinese (21.6%) compared to Indian 
children (16%)  [6] . The association of having siblings 
with a reduced odds of developing AD is consistent with 
the hygiene hypothesis, whereby an increased microbial 
load lowers the risk of developing allergic diseases.
 Most studies on antibiotic exposure have focused on 
asthma as an end point  [16, 17] . As of yet, there is no con-
clusive evidence to show that antibiotic treatment is a risk 
factor for AD. In a birth cohort study conducted in The 
Netherlands involving 2,764 families, in which informa-
tion was collected on antibiotic exposure in the first 
6  months of life, there was no association of antibiotic 
exposure with AD in the children who were followed up 
for 2 years  [18] . However, other groups have reported ob-
servations similar to those in this study, albeit from ret-
rospective studies conducted in older children  [19–21] . 
Interestingly, Wickens et al.  [22] reported that antibiotic 
exposure in the first 15 months of infancy was associated 
with the development of AD (OR 1.83, 95% CI 1.10–3.05) 
and rash (OR 1.61, 95% CI 1.02–2.53) after 15 months, 
which persisted till 4 years in a birth cohort. This is in 
agreement with our observation that antibiotic exposure 
in the first 6 months of life was significantly associated 
with the development of doctor-diagnosed AD. Kuo et al. 
 [23] suggested that this could be due to the suppression 
of production of pro-Th1 cytokines, IL-6 and TNF-α by 
antibiotics  [24] , resulting in a predominant Th2 environ-
ment in the infant. Infants are born with Th2-skewed im-
mune responses and infections may skew towards a Th1 
response according to the hygiene hypothesis. Antibiotics 
also disrupt the gut microflora, potentially tipping the 
immune response balance towards the Th2 predomi-
nance associated with allergic diseases  [25] .
 We found that early-onset doctor-diagnosed AD was 
associated with allergen sensitization, while late-onset AD 
was not. This suggests that allergy may be associated with 
early AD but not late-onset AD. Associations between ear-
ly-onset AD and positive SPT reactivity to aeroallergens 
are well established  [26, 27].  Our findings are consistent 
with a defective skin barrier due to AD supporting the 
dermal route of sensitization to aeroallergens  [28, 29] .
 The limitations of our study were that the information 
was self-reported and there may have been recall and in-
formation bias. In addition, the design of the question-
naire did not allow us to phenotype into transient and 
persistent eczema cases. Longer follow-up will be needed 
to establish the proposed phenotypes. The strengths of 
this study were the large sample size and the prospective 
collection of data from the prenatal stage.
 In conclusion, we found that early-onset AD was main-
ly associated with familial factors, such as maternal aller-
gy, while late-onset AD was associated with antibiotic 
treatment or the consumption of probiotics. Both familial 
and environmental factors as well as antibiotic treatment 
were associated with the development of AD between the 
ages of 6 and 12 months. Our study supports the concept 
that different phenotypes of AD exist in young children.
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